IDERA PHARMACEUTICALS, INC. (30)

Browse by Contract Category

Contracts

Consulting Agreement, dated December 29, 2020, between the Company and R. Clayton Fletcher (Filed With SEC on January 5, 2021)
Amendment to the Securities Purchase Agreement and Registration Rights Agreement, dated December 11, 2020, by and among Idera Pharmaceuticals, Inc., Pillar Partners Foundation,... (Filed With SEC on December 15, 2020)
Voting Agreement, dated April 7, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on April 7, 2020)
Second Amendment dated January 13, 2020 to Lease Agreement dated March 31, 2015 between Idera Pharmaceuticals, Inc. and 505 Eagleview Boulevard Associates, L.P (Filed With SEC on March 12, 2020)
Description of the Idera Pharmaceuticals, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
Form of Performance-Based Restricted Stock Agreement under the 2013 Stock Incentive Plan (Filed With SEC on October 29, 2020)
First Amendment to Purchase Agreement, dated as of September 2, 2020, by and between Idera Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 3, 2020)
Form of Pre-Funded Warrant (Filed With SEC on July 15, 2020)
Securities Purchase Agreement, dated July 13, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on July 15, 2020)
Registration Rights Agreement, dated July 13, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on July 15, 2020)
Form of Common Warrant (Filed With SEC on July 15, 2020)
Form of Pre-Funded Warrant (Filed With SEC on April 7, 2020)
Registration Rights Agreement, dated April 7, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on April 7, 2020)
Securities Purchase Agreement, dated April 7, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on April 7, 2020)
Form of Common Warrant (Filed With SEC on April 7, 2020)
Warrant Amendment Agreement, dated as of December 23, 2019, by and among Idera Pharmaceuticals, Inc. and certain holders of warrants named therein (Filed With SEC on March 12, 2020)
Registration Rights Agreement, dated December 23, 2019, by and among Idera Pharmaceuticals, Inc. and certain investors named therein (Filed With SEC on March 12, 2020)
Voting Agreement, dated as of December 23, 2019, by and among Idera Pharmaceuticals, Inc. and certain investors named therein (Filed With SEC on March 12, 2020)
Amendment to Severance and Change of Control Agreement, dated January 27, 2020, by and between the Company and Dr. Jonathan Yingling (Filed With SEC on January 27, 2020)
Form of Vincent J. Milano Restricted Stock Unit Agreement (Filed With SEC on January 15, 2020)
Amendment to Employment Agreement, dated January 10, 2020, by and between the Company and Vincent J. Milano (Filed With SEC on January 15, 2020)
Securities Purchase Agreement, dated December 23, 2019, by and among the institutional investors named therein (Filed With SEC on December 23, 2019)
Form of Warrant (Filed With SEC on December 23, 2019)
Clinical Trial Collaboration and Supply Agreement, effective August 27, 2019, by and between AbbVie Inc. and Idera Pharmaceuticals, Inc (Filed With SEC on November 6, 2019)
Employment Offer Letter, dated June 26, 2019, by and between Idera Pharmaceuticals, Inc. and Elizabeth Tarka (Filed With SEC on August 8, 2019)
Form of Restricted Stock Agreement under the 2013 Stock Incentive Plan (Filed With SEC on August 8, 2019)
Clinical Trial Collaboration and Supply Agreement, by and between Idera Pharmaceuticals, Inc. and Bristol-Myers Squibb Company, dated March 11, 2019 (Filed With SEC on May 2, 2019)
Employment Offer Letter, dated October 15, 2015, by and between Idera Pharmaceuticals, Inc. and John J. Kirby (Filed With SEC on March 6, 2019)
Purchase Agreement, dated as of March 4, 2019, by and between Idera Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 6, 2019)
Registration Rights Agreement, dated as of March 4, 2019, by and between Idera Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 6, 2019)